| First Author | Merienne N | Year | 2017 |
| Journal | Cell Rep | Volume | 20 |
| Issue | 12 | Pages | 2980-2991 |
| PubMed ID | 28930690 | Mgi Jnum | J:254932 |
| Mgi Id | MGI:6104134 | Doi | 10.1016/j.celrep.2017.08.075 |
| Citation | Merienne N, et al. (2017) The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes. Cell Rep 20(12):2980-2991 |
| abstractText | Neurodegenerative disorders are a major public health problem because of the high frequency of these diseases. Genome editing with the CRISPR/Cas9 system is making it possible to modify the sequence of genes linked to these disorders. We designed the KamiCas9 self-inactivating editing system to achieve transient expression of the Cas9 protein and high editing efficiency. In the first application, the gene responsible for Huntington''s disease (HD) was targeted in adult mouse neuronal and glial cells. Mutant huntingtin (HTT) was efficiently inactivated in mouse models of HD, leading to an improvement in key markers of the disease. Sequencing of potential off-targets with the constitutive Cas9 system in differentiated human iPSC revealed a very low incidence with only one site above background level. This off-target frequency was significantly reduced with the KamiCas9 system. These results demonstrate the potential of the self-inactivating CRISPR/Cas9 editing for applications in the context of neurodegenerative diseases. |
